Image Trademark with Serial Number 79278845
Status: 700 - Registered
Image for trademark with serial number 79278845
Serial Number
79278845
Registration Number
6253552
Status
700 - Registered
Status Date
2021-01-26
Filing Date
2019-12-13
Registration Number
6253552
Registration Date
2021-01-26
Mark Drawing
2000 - Illustration: Drawing or design without any word(s)/letter(s)/ number(s) Typeset
Design Searches
280103 - Inscriptions in Chinese, Japanese, Korean, Vietnamese or other Asian characters.
Published for Opposition Date
2020-11-10
Attorney Name
Alyson J. DiLena
Law Office Assigned Location Code
L40
Employee Name
MESSICK, TABITHA LEE
Statements
Certificate of Correction for Registration
In the statement, line 2 and 3 should be deleted, and Medical City Avenue, 101 room of first floor, QB3 building, Taizhou, Jiangsu China 225300 should be inserted.
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text
THE NON-LATIN CHARACTERS THAT TRANSLITERATE TO "YI YAO"
Description of Mark
The mark consists of four non-Latin characters.
Goods and Services
Biochemical medicines for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; antiseptics; collyrium; suppositories; medicinal oil solutions for medical purposes; hemostatic paste for medical purposes; bone paste for medical purpose; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; candy, medicated; candy for medical purposes; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes; dietetic preparations adapted for medical use; mineral food supplements; nutritional supplements; drugs for human purposes, namely, medicines for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; bacterial poisons; pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; pharmaceutical preparations in the form of tablets, lozenges, chews, gels, fast dispersing dosage forms, films, ovules, sprays, buccal and mucoadhesive patches for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; bulk drugs, namely, active pharmaceutical ingredients in the nature of drug delivery agents in the form of tablets, lozenges, chews, gels, fast dispersing dosage forms, films, ovules, sprays, buccal and mucoadhesive patches that facilitate the delivery of pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemical-pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; drugs for medical purposes in the nature of prescription apoptosis targeted compounds, kinase inhibitors and senolytic drugs; prescription drugs for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; biological preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease medical purposes; chemical preparations for pharmaceutical or medical purposes, namely, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemico-pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; pharmaceutical preparations in the form of injectables for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; pharmaceutical preparations in the form of tablet for the treatment of cancer, tumors, blood-related diseases, infectious diseases, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemical preparations for medical purposes, namely, active pharmaceutical ingredients in the nature of drug delivery agents in the form of powders, liquids, and capsules that provide controlled release of active ingredients for a wide variety of pharmaceuticals; chemical preparations for medical purposes, namely, active pharmaceutical ingredients in the nature of drug delivery agents in the form of tablets that facilitate the delivery of pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; pharmaceutical preparations in the nature of transdermal patches for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; medicines for dental purposes; chemical preparations for medical purposes for treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; antibiotics; tablets for medical purposes in the nature of vitamin tablets
Transliteration Statement
The non-Latin characters in the mark transliterate to ¿YA SHENG YI YAO¿ and ¿YA SHENG¿ has no meaning in English and ¿YI¿ means ¿DOCTOR, MEDICAL SCIENCE, CURE¿ and ¿YAO¿ means ¿MEDICINE, DRUG, REMEDY¿ in English.
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2020-02-19
Primary Code
005
Current Trademark Owners
Party Name
Jiangsu Ascentage Pharma Inc.
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (Limited Corporation).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Jiangsu Ascentage Pharma Inc.
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (Limited Corporation).
Address
Please log in with your Justia account to see this address.
Party Name
Jiangsu Ascentage Pharma Inc.
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (Limited Corporation).
Address
Please log in with your Justia account to see this address.
Party Name
Jiangsu Ascentage Pharma Inc.
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (Limited Corporation).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Alyson J. DiLena
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1514786
International Registration Date
2019-12-13
International Publication Date
2020-02-13
International Renewal Date
2029-12-13
Auto Protection Date
2021-08-13
International Status
001 - Request for extension of protection established
International Status Date
2020-02-13
Priority Claimed In
False
First Refusal In
True
Trademark Events
Event DateEvent Description
2020-02-13SN ASSIGNED FOR SECT 66A APPL FROM IB
2020-02-19NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2020-02-25APPLICATION FILING RECEIPT MAILED
2020-03-13ASSIGNED TO EXAMINER
2020-03-21NON-FINAL ACTION WRITTEN
2020-03-22NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
2020-04-07REFUSAL PROCESSED BY MPU
2020-04-07NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
2020-04-24REFUSAL PROCESSED BY IB
2020-09-16TEAS RESPONSE TO OFFICE ACTION RECEIVED
2020-09-16CORRESPONDENCE RECEIVED IN LAW OFFICE
2020-09-16TEAS/EMAIL CORRESPONDENCE ENTERED
2020-10-05EXAMINERS AMENDMENT -WRITTEN
2020-10-05EXAMINERS AMENDMENT E-MAILED
2020-10-05NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2020-10-05EXAMINER'S AMENDMENT ENTERED
2020-10-05APPROVED FOR PUB - PRINCIPAL REGISTER
2020-10-06TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2020-10-06ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2020-10-06TEAS CHANGE OF CORRESPONDENCE RECEIVED
2020-10-21NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2020-10-21NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
2020-10-21NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
2020-11-08NOTIFICATION PROCESSED BY IB
2020-11-10PUBLISHED FOR OPPOSITION
2020-11-10OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2021-01-26REGISTERED-PRINCIPAL REGISTER
2021-04-26FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
2021-04-30FINAL DISPOSITION PROCESSED
2021-04-30FINAL DISPOSITION NOTICE SENT TO IB
2021-05-23FINAL DECISION TRANSACTION PROCESSED BY IB
2021-06-24TEAS SECTION 7 REQUEST RECEIVED
2021-11-20CASE ASSIGNED TO POST REGISTRATION PARALEGAL
2021-11-23CORRECTION UNDER SECTION 7 ¿ PROCESSED